JAKAFI for Myeloproliferative disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 29 adverse event reports in the FDA FAERS database where JAKAFI was used for Myeloproliferative disorder.
Most Reported Side Effects for JAKAFI
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Platelet count decreased | 165 | 9.4% | 9 | 28 |
| Fatigue | 162 | 9.3% | 6 | 12 |
| Haemoglobin decreased | 150 | 8.6% | 6 | 19 |
| Anaemia | 145 | 8.3% | 5 | 23 |
| Dizziness | 106 | 6.1% | 1 | 5 |
| Diarrhoea | 105 | 6.0% | 4 | 5 |
| Headache | 102 | 5.8% | 1 | 4 |
| Death | 92 | 5.3% | 92 | 23 |
| Asthenia | 74 | 4.2% | 5 | 14 |
| Nausea | 72 | 4.1% | 1 | 5 |
| Weight increased | 70 | 4.0% | 0 | 4 |
| Blood count abnormal | 63 | 3.6% | 1 | 10 |
| Contusion | 61 | 3.5% | 2 | 1 |
| Dyspnoea | 58 | 3.3% | 3 | 8 |
| Drug dose omission | 54 | 3.1% | 2 | 8 |
Other Indications for JAKAFI
Myelofibrosis (1,314)
Polycythaemia vera (81)
Myelodysplastic syndrome (31)
Splenomegaly (29)
Essential thrombocythaemia (18)
Blood disorder (12)
Leukaemia (8)
Polycythaemia (8)
Myeloid metaplasia (6)